Karen A. Hanson

2.3k total citations
29 papers, 1.7k citations indexed

About

Karen A. Hanson is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Karen A. Hanson has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 12 papers in Epidemiology and 10 papers in Surgery. Recurrent topics in Karen A. Hanson's work include Inflammatory Bowel Disease (18 papers), Microscopic Colitis (10 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Karen A. Hanson is often cited by papers focused on Inflammatory Bowel Disease (18 papers), Microscopic Colitis (10 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Karen A. Hanson collaborates with scholars based in United States and South Korea. Karen A. Hanson's co-authors include William J. Sandborn, Edward V. Loftus, Sunanda V. Kane, William A. Faubion, David H. Bruining, Waqqas Afif, William J. Tremaine, Russell D. Cohen, Darrell S. Pardi and Stephen B. Hanauer and has published in prestigious journals such as Gastroenterology, The American Journal of Gastroenterology and Mayo Clinic Proceedings.

In The Last Decade

Karen A. Hanson

29 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen A. Hanson United States 15 1.0k 772 529 425 260 29 1.7k
A. D’Hoore Belgium 17 1.2k 1.2× 956 1.2× 923 1.7× 190 0.4× 147 0.6× 46 1.9k
Irwin M. Gelernt United States 21 1.4k 1.4× 1.2k 1.5× 1.1k 2.0× 175 0.4× 148 0.6× 41 2.4k
Saima Basit Denmark 17 605 0.6× 666 0.9× 398 0.8× 225 0.5× 60 0.2× 38 1.9k
Melissa Smith United Kingdom 19 471 0.5× 347 0.4× 196 0.4× 57 0.1× 41 0.2× 54 1.2k
Ariella Bar‐Gil Shitrit Israel 20 390 0.4× 440 0.6× 403 0.8× 313 0.7× 74 0.3× 78 1.2k
A. Dabadie France 21 477 0.5× 608 0.8× 882 1.7× 156 0.4× 379 1.5× 82 1.6k
Dan Carter Israel 19 441 0.4× 325 0.4× 561 1.1× 39 0.1× 211 0.8× 70 1.1k
Franck Brazier France 16 662 0.7× 561 0.7× 543 1.0× 117 0.3× 131 0.5× 68 1.1k
P. Lilos Israel 14 580 0.6× 379 0.5× 349 0.7× 66 0.2× 74 0.3× 30 1.4k
William M. Michener United States 16 1.3k 1.2× 931 1.2× 773 1.5× 232 0.5× 169 0.7× 40 1.9k

Countries citing papers authored by Karen A. Hanson

Since Specialization
Citations

This map shows the geographic impact of Karen A. Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen A. Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen A. Hanson more than expected).

Fields of papers citing papers by Karen A. Hanson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen A. Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen A. Hanson. The network helps show where Karen A. Hanson may publish in the future.

Co-authorship network of co-authors of Karen A. Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of Karen A. Hanson. A scholar is included among the top collaborators of Karen A. Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen A. Hanson. Karen A. Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hansel, Stephanie L., Jeffrey D. McCurdy, John M. Barlow, et al.. (2018). Clinical Benefit of Capsule Endoscopy in Crohn’s Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement. Inflammatory Bowel Diseases. 24(7). 1582–1588. 27 indexed citations
2.
Yadav, Siddhant, William S. Harmsen, Darrell S. Pardi, et al.. (2014). Su1420 Ustekinumab Treatment for Crohn's Disease in Clinical Practice: Experience At a Tertiary Medical Center. Gastroenterology. 146(5). S–464. 7 indexed citations
3.
Kane, Sunanda V., William J. Sandborn, Brandon Becker, et al.. (2012). Natalizumab for moderate to severe Crohnʼs disease in clinical practice: The Mayo Clinic Rochester experience. Inflammatory Bowel Diseases. 18(12). 2203–2208. 35 indexed citations
4.
Bruining, David H., Hassan Siddiki, Joel G. Fletcher, et al.. (2011). Benefit of Computed Tomography Enterography in Crohnʼs Disease: Effects on Patient Management and Physician Level of Confidence§†. Inflammatory Bowel Diseases. 18(2). 219–225. 57 indexed citations
5.
Swoger, Jason M., Edward V. Loftus, William J. Tremaine, et al.. (2010). Adalimumab for Crohnʼs disease in clinical practice at Mayo clinic: The first 118 patients. Inflammatory Bowel Diseases. 16(11). 1912–1921. 38 indexed citations
6.
Afif, Waqqas, Edward V. Loftus, William A. Faubion, et al.. (2010). Clinical Utility of Measuring Infliximab and Human Anti-Chimeric Antibody Concentrations in Patients With Inflammatory Bowel Disease. The American Journal of Gastroenterology. 105(5). 1133–1139. 409 indexed citations
7.
Sandborn, William J., Darrell S. Pardi, William J. Tremaine, et al.. (2009). W1095 Natalizumab Use in Clinical Practice in Patients with Moderate to Severe Crohn's Disease. Gastroenterology. 136(5). A–653. 1 indexed citations
8.
Afif, Waqqas, Jonathan A. Leighton, Stephen B. Hanauer, et al.. (2009). Open-label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab. Inflammatory Bowel Diseases. 15(9). 1302–1307. 101 indexed citations
9.
Solem, Craig A., Edward V. Loftus, Joel G. Fletcher, et al.. (2008). Small-bowel imaging in Crohn's disease: a prospective, blinded, 4-way comparison trial. Gastrointestinal Endoscopy. 68(2). 255–266. 247 indexed citations
10.
Hanson, Karen A., et al.. (2008). Clinical features and outcome of patients with inflammatory bowel disease who use narcotics: A case–control study. Inflammatory Bowel Diseases. 15(5). 772–777. 66 indexed citations
11.
Swoger, Jason M., Edward V. Loftus, Darrell S. Pardi, et al.. (2008). W1240 Adalimumab for Crohn's Disease in Clinical Practice At An Academic Medical Center: the First 118 Patients. Gastroenterology. 134(4). A–662. 1 indexed citations
12.
Chopra, Ashish, Darrell S. Pardi, Edward V. Loftus, et al.. (2005). Budesonide in the treatment of inflammatory bowel disease: The first year of experience in clinical practice. Inflammatory Bowel Diseases. 12(1). 29–32. 39 indexed citations
13.
Mahadevan, Uma, Sunanda V. Kane, William J. Sandborn, et al.. (2005). Intentional infliximab use during pregnancy for induction or maintenance of remission in Crohn's disease. Alimentary Pharmacology & Therapeutics. 21(6). 733–738. 179 indexed citations
14.
Sandborn, William J., Stephen B. Hanauer, Edward V. Loftus, et al.. (2004). An Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects with Prior Loss of Response or Intolerance to Infliximab for Crohn's Disease. The American Journal of Gastroenterology. 99(10). 1984–1989. 211 indexed citations
15.
Hanson, Karen A.. (2002). BCG installations for bladder cancer and latent tuberculosis infection.. PubMed. 22(2). 132–4. 1 indexed citations
16.
Kusek, John W., Allison M. Ahrens, Pamela K. Burrows, et al.. (2002). Recruitment for a clinical trial of drug treatment for benign prostatic hyperplasia. Urology. 59(1). 63–67. 13 indexed citations
17.
Mitchell, James E., Linda Fletcher, Karen A. Hanson, et al.. (2001). The Relative Efficacy of Fluoxetine and Manual-Based Self-Help in the Treatment of Outpatients With Bulimia Nervosa. Journal of Clinical Psychopharmacology. 21(3). 298–304. 53 indexed citations
18.
Blute, Michael L., Thayne R. Larson, Karen A. Hanson, & Bernard F. King. (1998). Current Status of Transurethral Thermotherapy at the Mayo Clinic. Mayo Clinic Proceedings. 73(6). 597–602. 5 indexed citations
19.
Roehrborn, Claus G., Cynthia J. Girman, Thomas Rhodes, et al.. (1997). Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. Urology. 49(4). 548–557. 126 indexed citations
20.
Rhodes, Thomas, Cynthia J. Girman, Steven J. Jacobsen, et al.. (1995). Does the mode of questionnaire administration affect the reporting of urinary symptoms?. Urology. 46(3). 341–345. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A. D’Hoore Breakdown of academic impact, for papers by Irwin M. Gelernt Breakdown of academic impact, for papers by Saima Basit Breakdown of academic impact, for papers by Melissa Smith Breakdown of academic impact, for papers by Ariella Bar‐Gil Shitrit Breakdown of academic impact, for papers by A. Dabadie Breakdown of academic impact, for papers by Dan Carter Breakdown of academic impact, for papers by Franck Brazier Breakdown of academic impact, for papers by P. Lilos Breakdown of academic impact, for papers by William M. Michener
Rankless by CCL
2026